Try our Advanced Search for more refined results

Neogenix Oncology, Inc. v. Gordon et al

  1. April 22, 2016

    Nixon Peabody Says Intel's Tapped Out In Biotech Stock Row

    Nixon Peabody LLP continued Friday to push back against Neogenix Oncology Inc.'s demands that the firm produce more intel on stock fees in the cancer treatment developer's malpractice suit, telling a New York federal judge the firm has already given all it can.

  2. April 08, 2016

    Nixon Peabody Can't Dodge Stock Fee Queries, Biotech Says

    Neogenix Oncology Inc. in a Friday filing again pressed Nixon Peabody LLP for more information over stock fees in a legal malpractice suit alleging former executives and lawyers contributed to the cancer treatment developer's downfall.

  3. December 10, 2015

    Biotech Wants Answers On Ex-GC's Role In Securities Scheme

    Cancer treatment developer Neogenix Oncology Inc. wants answers from its former chief legal officer about the securities sale program that bankrupted the company, moving in New York federal court on Wednesday to force the attorney to answer questions about his role in the scheme.

  4. September 30, 2015

    Nixon Peabody, Mintz Levin Can't Escape Malpractice Row

    A New York federal judge on Wednesday refused Nixon Peabody LLP, Mintz Levin Cohn Ferris Glovsky & Popeo PC and others' attempt to ditch a suit alleging they contributed to Neogenix Oncology Inc.'s bankruptcy, finding too many questions remained.

  5. February 18, 2015

    Nixon Peabody, Mintz Levin Seek Exit From Malpractice Row

    Nixon Peabody LLP on Tuesday asked a federal judge to ax the malpractice suit claiming it and Mintz Levin Cohn Ferris Glovsky and Popeo PC contributed to a now-bankrupt biotech company's downfall, arguing Neogenix Oncology Inc. alleges the conduct occurred in New York and is now improperly asserting Washington, D.C., law claims.

  6. January 29, 2015

    Nixon Peabody, Mintz Levin Using Barred Defense, Court Told

    Nixon Peabody LLP and Mintz Levin Cohn Ferris Glovsky & Popeo PC cannot kill a malpractice suit by saying the plaintiff is as guilty as the law firms in failing to stop a former executive's alleged illegal fundraising because applicable state laws prohibit the defense, now-bankrupt biotech company Neogenix Oncology Inc. argued Wednesday.

  7. December 22, 2014

    Nixon Peabody, Mintz Levin Blitz Biotech's Legal Mal Suit

    Nixon Peabody LLP, Mintz Levin Cohn Ferris Glovsky and Popeo PC, and ex-Neogenix Oncology Inc. executives urged a New York federal judge on Monday to toss a suit alleging breaches of fiduciary duty and legal malpractice and implicating them in the now-bankrupt biotech company's downfall.

  8. July 23, 2014

    Nixon Peabody, Mintz Levin Blamed For Biotech's Downfall

    A lawsuit filed in New York federal court Tuesday by Neogenix Oncology Inc. against its former executives also targets Nixon Peabody LLP and Mintz Levin Cohn Ferris Glovsky & Popeo PC, alleging breach of fiduciary duty and malpractice and implicating them in the downfall of the now-bankrupt biotech company.